In vitro and Lactation Responses in Mid-lactating Dairy Cows Fed Protected Amino Acids and Fat

por Nam, I. S., Choi, J. H., Seo, K. M., Ahn, J. H.
Publicado 2014

A small cell osteosarcoma on the calcaneus--a case report.

por Park, Y. K., Ryu, K. N., Ahn, J. H., Yang, M. H.
Publicado 1995

Calcifying fibrous pseudotumor of mediastinum--a case report.

por Jeong, H. S., Lee, G. K., Sung, R., Ahn, J. H., Song, H. G.
Publicado 1997

Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10–17)

por Choi, Y J, Lee, S H, Lee, J-L, Ahn, J-H, Lee, K-H, You, D, Hong, B, Hong, J H, Ahn, H
Publicado 2015

Preparedness for COVID-19 infection prevention in Korea: a single-centre experience

por Kim, Y.J., Jeong, Y.J., Kim, S.H., Kim, Y.J., Lee, S.Y., Kim, T.Y., Choi, M.S., Ahn, J.H.
Publicado 2020

Gemcitabine–oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed

por Lee, J-L, Ahn, J-H, Choi, M K, Kim, Y, Hong, S-W, Lee, K-H, Jeong, I-G, Song, C, Hong, B-S, Hong, J H, Ahn, H
Publicado 2014

Severe aplastic anemia induced by ticlopidine: report of two cases.

por Bahng, H., Lee, J. H., Suh, C., Ahn, J. H., Kim, S. B., Kim, S. W., Lee, K. H., Lee, J. S., Kim, W. K., Park, C. J., Chi, H. S., Kim, S. H.
Publicado 1998

Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial

por Kim, J.H., Kim, S.H., Jeon, M.K., Kim, J.E., Kim, K.H., Yun, K.-H., Jeung, H.-C., Rha, S.Y., Ahn, J.-H., Kim, H.S.
Publicado 2021

Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from th...

por Cho, E.H., Kim, J.-Y., Im, S.-A., Jung, K.H., Sohn, J., Lee, K.S., Chae, Y.S., Lee, K.H., Kim, J.H., Jang, J.-H., Ahn, J.H., Park, M.S., Lee, S.-Y., Park, Y.H.
Publicado 2021

Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase...

por Hyung, J., Lee, J.Y., Kim, J.E., Yoon, S., Yoo, C., Hong, Y.S., Jeong, J.H., Kim, T.W., Jeon, S., Jun, H.R., Jung, C.K., Jang, J.P., Kim, J., Chun, S.M., Ahn, J.H.
Publicado 2023